Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 8/20 | 0.67 |
| ▸ | SLC28A1 | O00337 | 2/20 | 0.67 |
| ▸ | SLC28A2 | O43868 | 2/20 | 0.67 |
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.67 |
| ▸ | STAT6 | P42226 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | DPP4 | P27487 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.57 |
| ▸ | GAPDH | P04406 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.57 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.57 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.57 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.57 |
| ▸ | PI4KA | P42356 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.57 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.57 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine SCHEMBL9591334 | 0.95 | ADORA3 (0.67) | SLC29A1SLC28A1SLC28A2SLC28A3STAT6 | |
| Guanosine SCHEMBL27427138 | 0.91 | P2RY2 (0.57) | SLC29A1SLC28A1SLC28A2SLC28A3STAT6 | |
| Inosine SCHEMBL23300589 | 0.90 | RNASEL (0.64) | SLC29A1SLC28A1SLC28A2SLC28A3ADORA1 | |
| Adenosine SCHEMBL8351411 | 0.90 | ADORA3 (0.74) | SLC29A1SLC28A1SLC28A2SLC28A3STAT6 | |
| Adenosine SCHEMBL2248919 | 0.90 | ADORA3 (0.74) | SLC29A1SLC28A1SLC28A2SLC28A3STAT6 | |
| Inosine SCHEMBL29860062 | 0.87 | SLC29A1 (0.73) | SLC29A1SLC28A1SLC28A2SLC28A3STAT6 | |
| Inosine SCHEMBL5066239 | 0.86 | SLC29A1 (0.56) | SLC29A1SLC28A1SLC28A2SLC28A3STAT6 | |
| Inosine SCHEMBL330178 | 0.85 | SLC29A1 (0.75) | SLC29A1SLC28A1SLC28A2SLC28A3STAT6 | |
| Inosine SCHEMBL4110068 | 0.85 | SLC29A1 (0.75) | SLC29A1SLC28A1SLC28A2SLC28A3STAT6 | |
| Inosine SCHEMBL2046912 | 0.85 | SLC29A1 (0.75) | SLC29A1SLC28A1SLC28A2SLC28A3STAT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019148062-A1 | FISH ATTRACTANTS | MITCHELL GREGORY (US) | 2019-08-01 | — | — | WO | claimed |
| EP-2601209-A1 | GENOMICS OF ACTINOPLANES UTAHENSIS | Bayer Intellectual Property GmbH (DE) | 2013-06-12 | — | — | EP | claimed |
| WO-2012016960-A1 | GENOMICS OF ACTINOPLANES UTAHENSIS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-02-09 | — | — | WO | claimed |
| JP-61207394-A | — | — | None | — | — | JP | disclosed |
| US-20240199709-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC (US) | 2024-06-20 | — | — | US | disclosed |
| US-11905315-B2 | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | SPOGEN BIOTECH INC. (US) | 2024-02-20 | — | — | US | disclosed |
| EP-3578659-B1 | ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN OR PEPTIDE EXPRESSION | CureVac SE (DE) | 2023-11-01 | — | — | EP | disclosed |
| CN-114028431-A | Compositions comprising bacterial strains | 4D制药研究有限公司 | 2022-02-11 | — | — | CN | disclosed |
| EP-3527662-B1 | NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED TUMOUR ANTIGEN | CUREVAC AG (DE) | 2022-01-26 | — | — | EP | disclosed |
| US-20210393755-A1 | NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED TUMOUR ANTIGEN | CUREVAC AG (DE) | 2021-12-23 | — | — | US | disclosed |
| CN-113423413-A | Compositions comprising bacterial strains | 4D制药研究有限公司 | 2021-09-21 | — | — | CN | disclosed |
| WO-2002100530-A2 | METHOD FOR CONTROLLING FERMENTATION | DEGUSSA AG (DE) | 2002-12-19 | — | — | WO | disclosed |
| WO-2002074798-A2 | THE GENOME OF A BIFIDOBACTERIUM | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2002-09-26 | — | — | WO | disclosed |
| CN-1371417-A | Corynebacterium glutamicum genes encoding metabolic pathway proteins | BASF AG (DE) | 2002-09-25 | — | — | CN | disclosed |
| US-20020132263-A1 | Enzyme detection/assay method and substrates | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-09-19 | — | — | US | disclosed |
| EP-1227152-A1 | Bacterial strain and genome of bifidobacterium | Société des Produits Nestlé S.A. (CH) | 2002-07-31 | — | — | EP | disclosed |
| US-6379911-B2 | ANALYZING NUCLEOSIDE HYDROLASES; DETECTING PARASITES | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY | 2002-04-30 | — | — | US | disclosed |
| US-20010019823-A1 | ENZYME DETECTION/ASSAY METHOD AND SUBSTRATES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2001-09-06 | — | — | US | disclosed |
| WO-1997031008-A1 | ENZYME DETECTION/ASSAY METHOD AND SUBSTRATES | INDUSTRIAL RESEARCH LIMITED (NZ) | 1997-08-28 | — | — | WO | disclosed |
| JP-S61207394-A | MONOMER HAVING NUCLEOTIDE-LIKE STRUCTURE AND PRODUCTION THEREOF | MITSUBISHI CHEM IND LTD | 1986-09-13 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010019823-A1 | ENZYME DETECTION/ASSAY METHOD AND SUBSTRATES | PNP, TREH, XDH | SLC29A1 234/4885SLC28A1 558/4885SLC28A2 604/4885 |
| US-20210393755-A1 | NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED TUMOUR ANTIGEN | HNRNPH3, HNRNPL, CPSF6 | SLC29A1 2698/4885SLC28A1 2605/4885SLC28A2 3032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.